2020
Chronic Disease Decision Making and “What Matters Most”
Fried TR, Street RL, Cohen AB. Chronic Disease Decision Making and “What Matters Most”. Journal Of The American Geriatrics Society 2020, 68: 474-477. PMID: 32043559, PMCID: PMC7197748, DOI: 10.1111/jgs.16371.Commentaries, Editorials and LettersMeSH KeywordsAged, 80 and overChronic DiseaseDecision Making, SharedFemaleHealth PrioritiesHumansMultimorbidityPatient-Centered CareConceptsOlder patientsChronic disease careClinical practice guidelinesPlan of careRobust outcome dataDifferent treatment optionsPatient-centered careMild cognitive impairmentAdverse eventsDisease careTreatment optionsChronic conditionsPractice guidelinesOutcome dataCognitive impairmentTreatment planPatientsCareMultimorbidityDisease decisionTherapyOutcomesOptionsSyndromeFrailty
2015
Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study
Tinetti ME, McAvay G, Trentalange M, Cohen AB, Allore HG. Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study. The BMJ 2015, 351: h4984. PMID: 26432468, PMCID: PMC4591503, DOI: 10.1136/bmj.h4984.Peer-Reviewed Original ResearchConceptsSerotonin-norepinephrine reuptake inhibitorsMultiple chronic conditionsSelective serotonin reuptake inhibitorsAdjusted hazard ratioRisk of deathCalcium channel blockersChronic conditionsHazard ratioΒ-blockersCohort studyReuptake inhibitorsAtrial fibrillationOlder adultsChannel blockersCardiovascular drugsSSRIs/serotonin-norepinephrine reuptake inhibitorsRenin-angiotensin system blockersNorepinephrine reuptake inhibitorsSerotonin reuptake inhibitorsCommon combinationRAS blockersSystem blockersStudy drugHeart failureThromboembolic disease